Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 15
2004 4
2005 6
2006 7
2007 1
2008 1
2009 3
2010 2
2011 1
2012 2
2013 3
2014 1
2015 4
2016 6
2017 7
2018 21
2019 20
2020 22
2021 20
2022 36
2023 28
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial.
Yulug B, Altay O, Li X, Hanoglu L, Cankaya S, Lam S, Velioglu HA, Yang H, Coskun E, Idil E, Nogaylar R, Ozsimsek A, Bayram C, Bolat I, Oner S, Tozlu OO, Arslan ME, Hacimuftuoglu A, Yildirim S, Arif M, Shoaie S, Zhang C, Nielsen J, Turkez H, Borén J, Uhlén M, Mardinoglu A. Yulug B, et al. Among authors: yildirim s. Transl Neurodegener. 2023 Jan 26;12(1):4. doi: 10.1186/s40035-023-00336-2. Transl Neurodegener. 2023. PMID: 36703196 Free PMC article. Clinical Trial.
Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases.
Turkez H, Altay O, Yildirim S, Li X, Yang H, Bayram C, Bolat I, Oner S, Tozlu OO, Arslan ME, Arif M, Yulug B, Hanoglu L, Cankaya S, Lam S, Velioglu HA, Coskun E, Idil E, Nogaylar R, Ozsimsek A, Hacimuftuoglu A, Shoaie S, Zhang C, Nielsen J, Borén J, Uhlén M, Mardinoglu A. Turkez H, et al. Among authors: yildirim s. Life Sci. 2023 Feb 1;314:121325. doi: 10.1016/j.lfs.2022.121325. Epub 2022 Dec 26. Life Sci. 2023. PMID: 36581096 Free article.
Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
Gozeler MS, Ekinci Akdemir FN, Yildirim S, Sahin A, Eser G, Askin S. Gozeler MS, et al. Among authors: yildirim s. Int J Pediatr Otorhinolaryngol. 2019 Jul;122:70-75. doi: 10.1016/j.ijporl.2019.04.004. Epub 2019 Apr 5. Int J Pediatr Otorhinolaryngol. 2019. PMID: 30978472
The effectiveness of eugenol against cisplatin-induced ototoxicity.
Sakat MS, Kilic K, Akdemir FNE, Yildirim S, Eser G, Kiziltunc A. Sakat MS, et al. Among authors: yildirim s. Braz J Otorhinolaryngol. 2019 Nov-Dec;85(6):766-773. doi: 10.1016/j.bjorl.2018.07.007. Epub 2018 Aug 7. Braz J Otorhinolaryngol. 2019. PMID: 30126770 Free PMC article.
Cerebrolysin Alleviating Effect on Glutamate-Mediated Neuroinflammation Via Glutamate Transporters and Oxidative Stress.
Avci S, Gunaydin S, Ari NS, Karaca Sulukoglu E, Polat OE, Gecili I, Yeni Y, Yilmaz A, Genc S, Hacimuftuoglu A, Yildirim S, Mokresh MY, Findik DG, Tsatsakis A, Margina D, Tsarouhas K, Wallace DR, Taghizadehghalehjoughi A. Avci S, et al. Among authors: yildirim s. J Mol Neurosci. 2022 Nov;72(11):2292-2302. doi: 10.1007/s12031-022-02078-8. Epub 2022 Nov 4. J Mol Neurosci. 2022. PMID: 36333611
186 results